An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae
Abstract
Introduction. Streptococcus pneumoniae is a major cause of morbi-mortality in early childhood and elderly. However, a test to measure the antibody responses after specific vaccination is not available in Colombia.
Objective. An immunoenzymatic test was standardized for the measurement of serum IgG levels against 10 serotypes of S. pneumoniae in response to the specific vaccination.
Material and methods. Capsular polysaccharides 1, 3, 4, 5, 6B, 9V, 14, 18, 19F, 23F of S. pneumoniae were used as antigens in a solid-phase ELISA. These responses were characterized in a randomized selected healthy individuals from a Colombian population.
Results. The reference and control sera showed great reactivity against all the polysaccharides evaluated, especially against polysaccharide 14 and 19F. The lowest reactivity in these two sera was observed against polysaccharide 3 and 4. Among the children evaluated, polysaccharide 5/19F showed the highes pre-vaccination reactivity, and polysaccharide 14/19F showed the highest post-vaccination reactivity. Among the adults, polysaccharides 14 and 19F showed the greatest reactivity pre- and postvaccination.
For all the polysaccharides (excepting polysaccharide 5), an inverse association among high polysaccharide-specific pre-vaccination- and the increase of post-vaccination-IgG levels was observed.
Conclusion. This ELISA test reliably quantifies the serum levels of specific IgG against 10 serotypes of S. pneumoniae. According to the responses by healthy individuals, the current study validates parameters used internationally as an adequate the response to the 23-valent pneumococcal vaccine.
Downloads
References
Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol. 1995;33:2759-62.
Konradsen HB, Kaltoft MS. Invasive pneumococcal infections in Denmark from 1995 to 1999: Epidemiology, serotypes, and resistance. Clin Diagn Lab Immunol. 2002;9:358-65.
Rodgers GL, Arguedas A, Cohen R, Dagan R. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines. Vaccine. 2009;27:3802-10.
Instituto Nacional de Salud. Boletín Epidemiológico Semanal, semana 39. Fecha de consulta: 1° de noviembre de 2011. Disponible en: http://www.ins.gov.co/?idcategoria=90955.
Castañeda E, Agudelo CI, Regueira M, Corso A, Brandileone MC, Brandao AP, et al. Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: A SIREVA II project, 2000-2005. Pediatr Infect Dis J. 2009;28:e265-70.
Coughlin RT, White AC, Anderson CA, Carlone GM, Klein DL, Treanor J. Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine. 1998;16:1761-7.
Sabin Vaccine Institute. Simposio Subregional de Nuevas Vacunas: neumococo, rotavirus y VPH. Acta del Simposio Subregional de Nuevas Vacunas: neumococo, rotavirus y VPH, 2008. Fecha de consulta: 1 de noviembre 1 de 2011. Disponible en: http://www.sabin.org/files/attachment/Acta%20del%20Simposio%20Subregional%20de%20Nuevas%20Vacunas-%20Neumococo,%20Rotavirus%20
y%20VPH.pdf.
Medscape. Pneumococcal vaccine polyvalent. Fecha de consulta: ¿Día? de enero de 2011. Disponible en: http://
www.medscape.com/druginfo/monograph?cid=med&drugid=5546&drugname=Pneumovax+23+Inj&monotype=monograph&secid=6.
Instituto Nacional de Vigilancia de Medicamentos y Alimentos. Registros concedidos o renovados en febrero de 2010. Fecha de consulta: 6 de noviembre 6 de 2011. Disponible en: http://web.sivicos.gov.co/registros/201002.htm.
WHO Pneumococcal Serology Reference Laboratories. Training manual for enzyme linked immunosorbent assay for the quantitation of Streptococcus pneumoniae serotype specific IgG (Pn PS ELISA). Fecha de consulta: 10 de enero 2011. Disponible en: http://www.vaccine.uab.edu/ELISA%20protocol.pdf.
Bonilla FA, Bernstein IL, Khan DA, Ballas ZK, Chinen J, Frank MM, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol. 2005;94(Suppl.1):S1-63.
Wasserman RL, Sorensen RU. Evaluating children with respiratory tract infections: The role of immunization with bacterial polysaccharide vaccine. Pediatr Infect Dis J. 1999;18:157-63.
Koskela M. Serum antibodies to pneumococcal C polysaccharide in children: Response to acute pneumococcal otitis media or to vaccination. Pediatr Infect Dis J. 1987;6:519-26.
Concepcion NF, Frasch CE. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2001;8:266-72.
Henckaerts I, Goldblatt D, Ashton L, Poolman J. Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera. Clin Vaccine Immunol. 2006;13:356-60.
Romero-Steiner S, Frasch CE, Carlone G, Fleck RA, Goldblatt D, Nahm MH. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol. 2006;13:165-9.
Lawrence EM, Edwards KM, Schiffman G, Thompson JM, Vaughn WK, Wright PF. Pneumococcal vaccine in normal children. Primary and secondary vaccination. Am J Dis Child. 1983;137:846-50.
Paris K, Sorensen RU. Assessment and clinical interpretation of polysaccharide antibody responses. Ann Allergy Asthma Immunol. 2007;99:462-4.
Landesman SH, Schiffman G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis. 1981;3(Suppl.)S184-97.
Hedlund J, Ortqvist A, Konradsen HB, Kalin M. Recurrence of pneumonia in relation to the antibody response after pneumococcal vaccination in middle-aged and elderly adults. Scand J Infect Dis. 2000;32:281-6.
Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangsinmankong N. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol. 2006;118:1336-41.
Sanz I, Wei C, Eun-Hyung Lee F, Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol. 2008;20:67-82.
Ferreyra P, Nagao A, Costa-Carvalho B, Carneiro-Sampaio M. Syndrome of anti-polysaccharide antibodies deficiency with normal levels of immunoglobulins. Arch Alergia Inmunol Clin. 2001;32:109-16.
Sorensen R. Deficiencia de anticuerpos con inmunoglobulinas normales. Fecha de consulta: 6 de noviembre de 2011. Disponible en: http://www.archivos.alergia.org.ar/material/12002/2002_01_06_comentarios2.pdf.
Borrow R, Stanford E, Waight P, Helbert M, Balmer P, Warrington R, et al. Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease. Infect Immun. 2008;76:5305-9.
Douglas RM, Paton JC, Duncan SJ, Hansman DJ. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis. 1983;148:131-7.
Boyle RJ, Le C, Balloch A, Tang ML. The clinical syndrome of specific antibody deficiency in children. Clin Exp Immunol. 2006;146:486-92.
Some similar items:
- César A. Arias, Marylin Hidalgo, Jinnethe Reyes, Ana María Cárdenas, Lorena Díaz, Sandra Ríncon, Natasha Vanegas, Paula Lucía Díaz, Elizabeth Castañeda, Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci , Biomedica: Vol. 28 No. 2 (2008)
- Eliana Parra, Elizabeth Castañeda, Jaime Moreno, Identification of Haemophilus influenzae, Streptococcus pneumoniae and Neisseria meningitidis by polymerase chain reaction , Biomedica: Vol. 27 No. 3 (2007)
- Marylin Hidalgo, Claudia Santos, Carolina Duarte, Elizabeth Castañeda, Clara Inés Agudelo, Increase in erythromycin-resistant Streptococcus pneumoniae in Colombia, 1994-2008 , Biomedica: Vol. 31 No. 1 (2011)
- Daniel Echeverri, María de los Ángeles Vargas, Lorena Matta, Fernando Rosso, Janier Daniel Segura, Invasive Streptococcus pneumoniae infection (Austrian syndrome): a case report , Biomedica: Vol. 35 No. 1 (2015)
- lngrid J. Peñuela, Aura Lucía Leal, Elizabeth Castañeda, Nasopharingeal carriage and antimicrobial resistance to Streptococcus pneumoniae in children of a day care center in Santa Fe de Bogotá , Biomedica: Vol. 19 No. 3 (1999)
- Jaime Moreno, Elizabeth Castañeda, Molecular characterization of invasive isolations of penicillin-resistant Streptococcus pneumoniae recovered from adult patients. , Biomedica: Vol. 23 No. 1 (2003)
- Mariluz Hernández, Gloria Isabel Mejía, Hugo Trujillo, Jaime Robledo, Effectiveness of the antibiotics chloramphenicol and rifampin in the treatment of Streptococcus pneumoniae-induced meningitis and systemic infections. , Biomedica: Vol. 23 No. 4 (2003)
- Jaime Moreno, Vienvilay Phandanouvong, Elizabeth Castañeda, Molecular surveillance of invasive penicillin-resistant Streptococcus pneumoniae Colombian isolates recovered from children less than 5 years of age. , Biomedica: Vol. 24 No. 3 (2004)
- Clara Inés Agudelo, Jaime Moreno, Olga Marina Sanabria, María Victoria Ovalle, José Luis Di Fabio, Elizabeth Castañeda, Streptococcus pneumoniae: serotype evolution and patterns of antimicrobial susceptibility in invasive isolates from 11 years surveillance (1994 -2004) in Colombia. , Biomedica: Vol. 26 No. 2 (2006)
- Carolina Firacative, Jaime Moreno, Elizabeth Castañeda, Molecular characterization of Colombian invasive serotype 5 Streptococcus pneumoniae isolates recovered between 1994 and 2004. , Biomedica: Vol. 26 No. 2 (2006)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
